Zobrazeno 1 - 10
of 167
pro vyhledávání: '"S, Schleibner"'
Autor:
S. Schleibner, B. Banas, G.A. Mondragón-Ramírez, Laetitia Albano, Bernhard K. Krämer, Frank Lehner, L. Bäckman, O. Viklický, Helio Tedesco-Silva, Maciej Glyda, Paolo Rigotti, Bernard Charpentier, Nassim Kamar, Georges Mourad, Elisabeth Cassuto-Viguier
Background. Two large, prospective studies (12-03; OSAKA) compared the efficacy and tolerability of prolonged-release versus immediate-release tacrolimus in kidney transplant patients also receiving mycophenolate mofetil and low-dose corticosteroids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49fa12c5ff4f6a700ec341da0be35bb2
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-359801
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-359801
Publikováno v:
Value in Health. 21:S197-S198
Autor:
LaGreca G, S. Schleibner, Illner Wd, H. F. Welter, I. Theodorakis, E. Hancke, D. Abendroth, Walter Land
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 115:523-527
Third renal transplants were performed in 31 patients (25 men and 3 women: mean age 33 +/- 11 years) with terminal renal failure. Surgical complications occurred in four of them. Acute rejection crises were frequent (48%). In three cases acute humora
Infektionen nach Nierentransplantation unter dreifacher oder vierfacher immunsuppressiver Behandlung
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 115:443-446
To determine, whether the infection rate after renal transplantation is influenced by the intensity of immunosuppressive treatment, the postoperative course of 100 consecutive renal transplantations in 64 men and 36 women (mean age 44.1 [18-72] years
Publikováno v:
Clinical Transplantation. 22:372-377
Five prospective, multicentre adult renal studies of three yr duration conducted in Europe for which tacrolimus was used as the primary immunosuppressant in at least one treatment arm was identified. This was confirmed by literature review as the onl
Autor:
Gunnar Tydén, Lars Bäckman, D Taube, Karl-Heinz Dietl, John L. R. Forsythe, Ulrich Kunzendorf, Uwe Heemann, José M. Morales, J.P. van Hooff, S. Schleibner, Yves Vanrenterghem, Ferdinand Mühlbacher, Kerstin Claesson, David Talbot, Henrik Ekberg, Jean-Paul Squifflet, Walter Land
Publikováno v:
Transplantation. 72:63-69
BACKGROUND: Supplementation of immunosuppressive therapy with mycophenolate mofetil (MMF) has been found to reduce the rate of acute rejection in renal transplantation. We report a dose-finding study for MMF when administered in combination with low-
Autor:
I. A. Hauser, H.-N. Neumayer, A. D. Mayer, J. Dmitrewski, J.-P. Squifflet, T. Besse, B. Grabensee, B. Klein, F. W. Eigler, U. Heemann, R. Pichlmayr, M. Behrend, Y. Vanrenterghem, J. Donck, J. van Hooff, M. Christiaans, J. M. Morales, A. Andres, R. W. G. Johnson, C. Short, B. Buchholz, N. Rehmert, W. Land, S. Schleibner, J. L. R. Forsythe, D. Talbot, B.-G. Ericzon, C. Brattström, K. Claesson, F. Mühlbacher, E. Pohanka
Publikováno v:
Transplant International. 11:S73-S77
The efficacy and safety of tacrolimus- and cyclosporine-based immunosuppressive regimens were compared in a prospectively defined subgroup of kidney transplant recipients from the European, open, multicentre, 2:1 randomised, parallel group study. Pat
Publikováno v:
Clinical transplantation. 22(3)
Five prospective, multicentre adult renal studies of three yr duration conducted in Europe for which tacrolimus was used as the primary immunosuppressant in at least one treatment arm was identified. This was confirmed by literature review as the onl